Seoul, Feb 24 (SocialNews.XYZ) Celltrion, a major South Korean biopharmaceutical firm, on Monday said its new biosimilar for an autoimmune disease treatment has obtained approval from the European Commission (EC). The EC approved Celltrion's Avtozma,...
The post Celltrion’s autoimmune disease treatment gets approval in Europe appeared first on Social News XYZ.